Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
30 Jul, 26
The second Universal Definition of heart failure (HF) standardizes HF terminology, reclassifies HF phenotypes beyond rigid EF cutoffs, emphasizes pre-HF detection, social determinants, & global disparities to improve prevention, diagnosis, & care.
14 Jul, 26
ESHRE 2026
Key highlights of the sessions on fertility preservation presented at ESHRE from 5th to 8th July 2026 in London, UK.
30 Jul, 26Diabetologia.
- A multinational cross-sectional analysis was conducted in 20,822 T2DM patients (from AusDiab, NHANES, Mauritius survey, & ICMR-INDIAB)
- Younger patients had higher BMI, triglycerides, LDL-C, & lower HDL-C, implying a more adverse cardiometabolic profile, FPG & HbA1c peaked at ~45–60 yrs before declining, older adults had higher SBP & UACR
- Glycemic & lipid abnormalities were more pronounced at younger ages.
29 Jul, 26Indian J. Gastroente...
- Patients with gallstones had higher advanced glycation end product (AGE) intake than controls.
- The highest AGE intake quartile was associated with nearly double the odds of gallstones (OR 1.89).
- The association remained significant after adjusting for metabolic and lifestyle factors.
- Lower dietary AGE exposure may represent a potential strategy for gallstone prevention.
29 Jul, 26Int. J. Infect. Dis.
- Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales colonization was more common in patients with Clostridioides difficile infection (CDI).
- ESBL colonization independently increased the odds of CDI by nearly threefold (OR 2.86).
- Prior antibiotic exposure was also an independent risk factor for CDI (OR 2.67).
- ESBL screening may aid CDI risk stratification and antimicrobial stewardship.
29 Jul, 26Diabetes Ther.
- 1072 patients with T2DM & CKD were followed for 60.4 months to assess the link between time-averaged serum uric acid (TA-SUA) & renal outcomes
- Maintaining TA-SUA <360 μmol/L was associated with better renal survival & a 37% lower risk of adverse renal outcomes vs TA-SUA ≥360 μmol/L (aHR:0.63)
- Renal risk increased sharply above 360 μmol/L, the greatest benefit observed in patients with eGFR 30–59 mL/min/1.73 m²
29 Jul, 26
Featured
27 Jul, 26
27 Jul, 26
27 Jul, 26
